Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

AirStrip Acquires Palomar Tech to Enable Mobile EHR Access

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:FDAnews Device Daily Bulletin

This week San Antonio-based AirStrip Technologies announced that it was expanding its suite of mobile patient monitoring applications to enable physicians to more easily access information housed in various electronic…

Continue ReadingAirStrip Acquires Palomar Tech to Enable Mobile EHR Access

Mazor Robotics Received KFDA Approval for Renaissance System

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:FDAnews Device Daily Bulletin

MAZOR Surgical Robotics announced that it has received Korean Food and Drug Administration (KFDA) approval for its Renaissance System, a new generation surgical robot.

Continue ReadingMazor Robotics Received KFDA Approval for Renaissance System

MIT Engineers Develop New Glucose-Powered Implantable Medical Device

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:FDAnews Device Daily Bulletin

MIT engineers have developed a fuel cell that runs on the same sugar that powers human cells: glucose.

Continue ReadingMIT Engineers Develop New Glucose-Powered Implantable Medical Device

Merck Hit With Complete Response Letter on Potential Sarcoma Drug

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:Washington Drug Letter

The FDA has handed Merck a complete response letter on Taltorvic, a potential maintenance treatment for metastatic soft-tissue and bone sarcomas, calling for additional clinical trials to assess safety and…

Continue ReadingMerck Hit With Complete Response Letter on Potential Sarcoma Drug

Guidance Optimizes Genotoxicity Tests, Aids in Risk Characterization

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:Washington Drug Letter

The FDA has revised its guidance on testing a new drug’s genotoxicity to help drugmakers optimize the standard genetic toxicology battery and better predict potential human risks.

Continue ReadingGuidance Optimizes Genotoxicity Tests, Aids in Risk Characterization

FDA Wants Harder Approval Standards for Drug-Device Combo Diagnostics

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:Washington Drug Letter

Pharma companies seeking approval for drugs along with companion diagnostics could see quicker FDA decisions as the agency moves toward a stricter preapproval path for the diagnostic portion of companion…

Continue ReadingFDA Wants Harder Approval Standards for Drug-Device Combo Diagnostics

Drug Quality Still Lacking; FDA Considering QbD Incentives

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:Washington Drug Letter

BALTIMORE — Despite recurring pharma quality problems, drugmakers are still inclined to meet minimum manufacturing standards set by regulators, rather than make quality central to their business model.

Continue ReadingDrug Quality Still Lacking; FDA Considering QbD Incentives

House Subcommittee OKs FDA 2013 Spending Bill; Full Panel Vote Later

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:Washington Drug Letter

The House appropriations subcommittee that oversees FDA funding recommends fiscal 2013 appropriations that would slightly reduce agency spending.

Continue ReadingHouse Subcommittee OKs FDA 2013 Spending Bill; Full Panel Vote Later

PDUFA Bills Appear to Authorize FDA to Require Supplier Quality Accords: Expert

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:Washington Drug Letter

BALTIMORE — Proposed language redefining current good manufacturing practices (cGMP) included in both versions of omnibus FDA user fee legislation appears to give the agency new authority to require drugmakers…

Continue ReadingPDUFA Bills Appear to Authorize FDA to Require Supplier Quality Accords: Expert

Tackle Issues of Quality Control In the Contract’s Operations Section

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:The Food & Drug Letter

The operations portion of the supplier quality agreement deals with quality control issues that will be ongoing during a drug’s production.

Continue ReadingTackle Issues of Quality Control In the Contract’s Operations Section
  • Go to the previous page
  • 1
  • …
  • 599
  • 600
  • 601
  • 602
  • 603
  • 604
  • 605
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.